Provider of research and development services, specializing in treating and preventing human disease through the discovery, development, and commercialization of pharmaceutical products directed toward serving unmet medical needs. The company's drug development program has yielded an extensive portfolio of pharmaceutical candidates centering on the treatment of respiratory and central nervous systems disorders. Products and services are sold to the medical and other industries. The bulk of revenue is derived from activity in the pharmaceuticals industry. This company was capitalized by private investment and venture capital. Stock symbol: SEPR. Products include pharmaceutical enhancement R&D services.